Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Arteriovenous Fistula Tissue Bank

The recruitment status of this study is unknown because the information has not been verified recently.
Verified July 2010 by University of Nebraska.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
University of Nebraska
ClinicalTrials.gov Identifier:
NCT00836862
First received: February 3, 2009
Last updated: July 15, 2010
Last verified: July 2010
  Purpose

This project will bank sera, DNA and vascular specimens from patients undergoing arteriovenous fistula creation and revision


Condition Intervention
Kidney Failure, Chronic
Other: Biologic specimens

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: Arteriovenous Fistula Tissue Bank

Resource links provided by NLM:


Further study details as provided by University of Nebraska:

Biospecimen Retention:   Samples With DNA

Serum, Whole Blood, Tissue


Estimated Enrollment: 50
Study Start Date: February 2009
Estimated Primary Completion Date: November 2011 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
Arteriovenous Fistula Other: Biologic specimens
Banking of serum, DNA and tissue

  Eligibility

Ages Eligible for Study:   19 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

Patients will be eligible if they are 19 years of age or greater and have placement of an arteriovenous fistula planned witin 30 days.

Criteria

Inclusion Criteria:

  • Age 19 years of age or greater
  • Arteriovenous fistula placement for hemodialysis access scheduled within 30 days

Exclusion Criteria:

  • Incompetent to provide informed consent
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00836862

Locations
United States, Nebraska
University of Nebraska Medical Center/The Nebraska Medical Center Recruiting
Omaha, Nebraska, United States, 68105
Contact: LuAnn Larson, RN, BSN    402-559-8555    llarson@unmc.edu   
Principal Investigator: Troy J Plumb, MD         
Sponsors and Collaborators
University of Nebraska
  More Information

No publications provided

Responsible Party: Troy J. Plumb, MD, University of Nebraska Medical Center
ClinicalTrials.gov Identifier: NCT00836862     History of Changes
Other Study ID Numbers: 482-08-EP
Study First Received: February 3, 2009
Last Updated: July 15, 2010
Health Authority: United States: Institutional Review Board

Keywords provided by University of Nebraska:
Hemodialysis
Vascular access
Arteriovenous fistula

Additional relevant MeSH terms:
Arteriovenous Fistula
Fistula
Kidney Failure, Chronic
Renal Insufficiency
Arteriovenous Malformations
Cardiovascular Abnormalities
Cardiovascular Diseases
Congenital Abnormalities
Kidney Diseases
Pathological Conditions, Anatomical
Renal Insufficiency, Chronic
Urologic Diseases
Vascular Diseases
Vascular Fistula
Vascular Malformations

ClinicalTrials.gov processed this record on November 27, 2014